Author: admin

Bavaria Pamplona clinic celebrates its 10th anniversary.

Clinic Bavaria Pamplona celebrates its tenth anniversary.

the Center has made nearly 2,000 interventions with laser surgery and 500 with surgery intraocular.

Pamplona, 2011-September clinic Bavaria Pamplona (Avenida Sancho el Fuerte, 26) celebrates its 10th anniversary and is consolidated as a centre of reference in the conduct of operations with surgery laser in the province with nearly 2,000 interventions in ten years. In addition, the clinical team, composed of fourteen professionals include three ophthalmologists and an optical, has carried out almost 500 intraocular surgeries.

Bavaria Pamplona Clinic specialises in correcting the problems of eye strain, a condition afflicting 95% of Spaniards older than 55 years. These operations have been carried out with the two techniques available at present to fix presbyopia; the “ laser presbyopia ” or a Multifocal Intraocular lens implantation or “ crystalline artificial ”. This last intervention consists of replacing the lens with a lens that will make its functions, allowing the brain to choose the most appropriate approach in each case. It is a definitive solution that eliminates defects associated as myopia, hyperopia, or astigmatism and also prevents the formation of cataracts.

presbyopia is a visual problem which affects 65% of Spaniards older than 45 years, a percentage which stands at 95% once passed the 55. While it’s impossible to prevent illness, associated with the ageing of bodies, the possibility to remove it surgically. Since 2001, year in which Bavaria Clinic began operating this problem, first with laser and later with the implantation of multifocal intraocular lenses, spoke more than 20,000 people in Spain, with a 95% satisfaction rate and eliminating the use of glasses or contact lenses to 88 per cent of the treaties.

throughout this decade, Bavaria clinic in Pamplona team has treated nearly 3,000 patients and his work has been awarded the ISO 9001 quality certificate. The institution has signed numerous agreements with insurance companies, government agencies and local and national businesses. It also has several points of information in gyms, clubs and shopping malls.

On the other hand, from clinic Bavaria Pamplona is initiatives have been launched to educate the population about the importance of vision care, as free revisions on the occasion of the week of the Visual health or of the world Glaucoma day, and is carried out an intense solidarity work with glasses collection campaigns to countries in sawas for development. Also be has served free children from reception of different countries which spend the summers at Spain, and there have been talks in associations of retirees, housewives, etc. giving information on diseases such as cataracts, eye strain, myopia, hyperopia, astigmatism, retinal or macular degeneration. Also been free revisions to children from schools in a campaign of detection of lazy eye in children, a condition where early detection is very important.

“ During these ten years we have worked hard to improve the eye health our neighbours. We are grateful to patients the confidence in our team and we are committed to further develop this work every day and relentlessly ”, said Marta Díaz-Leante, Manager of clinic Bavaria Pamplona.

Clinic Bavaria

Clínica Baviera is a Spanish medical institution specializing in ophthalmology, with 60 centres, is present in several European countries (Spain, Germany, Austria, Holland, Italy). Founded more than 25 years ago, the quality of care, the permanent improvement of results and the incorporation of innovative and solvent techniques have been its raison d ’ être.

Read More

Trobalt r (retigabina) of GSK shows its potential to keep epilepsy patients free of crisis in the long term.

Trobalt r (retigabina) of GSK shows its potential to keep epilepsy patients free from crisis to long term.

Spain, 2011-September new data presented at the Congress of the European Federation of Neurological Societies show that more than 10% of patients with uncontrolled epilepsy that were treated with Trobalt (retigabina) associated to their usual treatment for two years, remained free of crisis for an entire year (1).

More than six million people in Europe suffer from epilepsy and about 30% still experiencing crisis despite getting treatment with the antiepileptic drugs available (2). In addition, crises are associated to an increase in physical problems, including fractures and bruises, and higher rates of prevalence of diseases or psychosocial problems, so their reduction is an important milestone in the management of this disease (3).

Tabled data from three studies long-term: study 212 (extension of the 205 study of dose range) and 303/304 studies (extensions of trials registration for retigabina, 1 and 2 RESTORE pivotal *), which included 222, 181 and 375 patients, respectively. In all three studies, patients were treated with retigabina for a minimum of six (n = 612), 12 (n = 450) or 24 (n = 183) months. During the transition to open extensions, adjusted the dose of retigabina, or remained, 900 mg/day (studies 212 and 304) or 1,200 mg/day (study 303). Thereafter, doses of retigabina (study 303 and 304: 600 – 1200mg/day and study 212: 900 – 1200mg/day) and of the antiepileptic drugs already receiving patients could change according to individual efficacy/tolerability of each patient (1).

The results show that patients treated with retigabina for at least 12 months, 12.4% (n = 56) were free of crisis during a continuous period of six months. In those treaties for at least 24 months, 11.5% (n = 21) it was for a year, showing retigabina (1)’s long-term effectiveness.

Professor Martin j. Brodie, studies presented at the Congress, noted, “ be free of crisis with minimum side effects or without them, is the best result we could expect in antiepileptic drugs refers. We had already previously obtained these results in short-term with retigabina treatments and it is now very positive knowledge that these results are also maintained long term ”.

In the trials pivotal, the most frequent adverse events with the use of this medication in combination with other antiepileptic drugs (occurred in at least 5% of patients and with twice as often than in the treated with placebo) were dizziness (23%), fatigue (15%), confusion (9%), dizziness (8%), tremor (8%), abnormal coordination (7%), double vision (7%), alteration of care (6%), memory loss (6%), and blurred vision (5%). In addition, the drowsiness occurred in 22% of patients treated with retigabina in comparison with 12 per cent of patients who received placebo.

Retigabina

Retigabina, developed by Valeant Pharmaceuticals International and GSK, received approval from the European Medicines Agency in March 2011 (7) for the adjunctive treatment of partial seizures with or without secondary generalization in adults with epilepsy (when the crisis occurs only in a part of the brain) (8). GSK and Valeant signed a global agreement exclusively for retigabina in 2008.

In controlled trials with retigabina, urinary retention occurred in 0.9% of patients who were treated with the medication compared to 0.5% of patients who received placebo. Throughout phase II/III there were four (0.3%) serious cases of urinary retention, three of which led to the withdrawal of treatment. Therefore, the EU recommended that retigabina be used with caution in patients at risk for urinary retention (7).

Retigabina also led to a prolongation of the QT (the heart’s electrical activity) interval when studied in its highest dose in healthy volunteers, in a specific study to do so. As precautionary measure, the EU also recommends holding an electrocardiogram before his administration in patients who have or may have congestive heart failure, ventricular hypertrophy, hypokalemia or hypomagnesemia, and in patients who begin treatment they have over 65 years of age (8).

GlaxoSmithKline

GlaxoSmithKIine (GSK), one of the companies leading global research-based pharmaceutical and health care, aims to improve the quality of life of people, making it possible that people have more vitality, feel better and live longer.

GSK has extensive experience in research in the area of Neurology and a considerable variety of drugs in research in the field of neuroscience, remains committed to improving the quality of life of people with neurological disorders.

References

(*) Retigabine Efficacy and Safety Trials for Partial Onset Epilepsy

(1). Brodie MJ, et to the. Seizure-free rates in patients receiving ≥6, ≥12 and ≥24 months of open-label Retigabine (Ezogabine). Abstract accepted for presentation at the 15th Congress of the European Federation of Neurological Societies (EFNS), Budapest, Hungary, 10-13 September 2011

(2). World Health Organization. Epilepsy in the WHO European region. Fostering epilepsy care in Europe. August 2010

(3). World Health Organization. Epilepsy facts & figures.

(4). Brodie MJ et to the. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology. 2010; 16; 75 (20): 1817

(5). GSK dates on file

(6). Porter et to the. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures. Neurology. 2007; 68: 1197

(7). EPAR Retigabina

(8). Retigabina data sheet technical

Read More

Best Doctors enters the list of “Fastest growing companies”, elaborated by Inc. magazine

Best Doctors enters the list of “ growing companies ”, drawn up by the prestigious Magazine Inc.

more than 3 million people in Spain have access to the care of Best Doctors.

Madrid, 2011-September Best Doctors, world leader in medical expert advisory services, has been included by the American magazine Inc. in its prestigious “ index of companies growing in United States ”. The a 116% growth in revenues of the company has served so Best Doctors take a place in the upper area of this ranking, perceived as a clear evidence of the corporate triumph.

From the direction of the company is valued as a success, part of the list of Inc., taking into account the nearly 7 million private companies that exist in United States. Also, the data enjoys even greater relevance if one takes into account the name and the path of other companies included in this list in previous editions, with figures similar to the Best Doctors: Microsoft, Oracle, or Timberland, among others.

Evan Falchuk, President of Best Doctors, attributed the success of the company to the fact of “ have been able to consolidate a health services company, designed in every detail to the extent of the patient ”. “ When it comes to their health or that of their family, people need certainties. At Best Doctors, we have the time, knowledge and the structure needed to help make better medical decisions; This is what sets us apart from others and makes us leaders ”, adds.

For its part, Ana Ruiz, Director of Best Doctors Spain, ensures that “ this business recognition is the result of the efforts and the tenacity of the Group of professionals who form Best Doctors ”.

Best Doctors

Best Doctors is a leading provider of medical information. Since its founding by doctors from Harvard University in 1989, his philosophy has been to put the best medicine available to patients. Best Doctors provides medical information to more than 20 million people in 30 countries, either looking for guidance from a health problem or providing direct access to the best specialist or medical treatment, there where you are. The exclusive network of 50,000 physicians elected by his colleagues as the most outstanding in his field optional is the basis of Best Doctors services. Knowledge and experience of these professionals give the best medical care as a result.

Best Doctors Spain

Best Doctors is present in Spain since 1992, where more than 3 million people have access to its range of medical services through 30 companies such as Aegon, Aviva, Nationale Nederlanden, Vidacaixa, Santander, Liberty Seguros, Genesis, American Express, Reale, El Corte Inglés or Endesa.

the headquarters of Best Doctors in Madrid is the center of operations for the development of activity in Europe and Australasia.

Read More

Theoretical classroom and clinical case presentation live

Online course in which the dentist will have the opportunity to monitor the classroom and the presentation of a clinical case live, interacting with Prof. Ms José Carlos Garófalo via chat (through an intermediary) in the comfort of your home or Office. Without offset costs and parking. Theoretical

worship leader: Ms. Prof. José Carlos Garófalo, specialist in restorative operative dentistry and Aesthetic, master in operative dentistry from FOUSP, Coordinator of refresher courses in aesthetic dentistry and in operative of the IES-CETAO-SP.

date: April 1, 2011

:

05:00 pm at 7:30 pm

Submissions through the website www.peakcursos.com.br/curso/saude/diagnostico-diferencial/>

Read More

Course for professionals in the field of implants and prostheses

Having as Coordinator Dr. Ricardo Passadore, the course aims to inform and update professionals in the field of implants and prostheses, using modern techniques developed from the creation of new appliances that optimize the oral rehabilitations.

Course

the course will start in March 15, 2011 in FAPES, located in Campevas Street, – São Paulo Perdizes – 197.

/worship leader Dr. Manoel Cosimo Pinto >/> Dr. Andres Portela

/guest teachers > Dr. Daniel Olszewer/Olszewer/> Dr. Efrain > Dr. Walter Israel Cabrera

More information by phones (11) 5184-0196 and 3672-1122 or by e-mail www.fapes.net/suportefapes@terra.com.br./> >

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips